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Finally, the product was purified by column chromatography on silica-gel when necessary.
Data of compounds 10 (already described) obtained following the general
procedure of enantioselective -fluorination described in the experimental part of the manuscript:
Methyl (R)-2-fluoro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (10a):
12 Following the general procedure, 70 mg (80% yield) of 10a were obtained as a white oily solid from 0.42 mmol of 1a using La(OTf)3 and (S,R)-ind-pybox. It was purified by column chromatography on silica-gel (hexane/AcOEt 4:1 
Following the general procedure, using Eu(OTf)3 and (S,R)-ind-pybox, 74 mg (85% yield) of 10d were obtained as a yellowish oil from 0.26 mmol of 2d. It was purified by column chromatography on silica-gel (hexane/AcOEt 4:1 
Tert-butyl (R)-2-fluoro-5,6-dimethoxy-1-oxo-2,3-dihydro-1H-indene-2-carbox-ylate (10h):
12 Following the general procedure, using Eu(OTf)3 and (S,R)-ind-pybox, 57 mg (66% yield) of 10h were obtained as a yellowish oil from 0.33 mmol of 2h. It was purified by column chromatography on silica-gel (hexane/AcOEt 9:1 
Synthesis of pybox ligands 4 and 5
To and argon purged solution of 2,6-pyridine carbonitrile (0.8 g, 6 mmol, 1 eq) in dry methanol (25 mL) was added 0.001 g of sodium, and the solution was stirred at room temperature for 48 hours. Glacial acetic acid (0.05 mL) was subsequently added, and the solution was stirred for additional 5 minutes. Then the solution was dried in vacuo affording an off white solid. This intermediate was reintroduced in dry dichloromethane (30 mL) and the desired amino-alcohol (13.4 mmol, 2.2 eq) was added in one portion to the solution. The mixture was refluxed under inert atmosphere for 4 hours, and then stirred for 48 h at room temperature. The mixture was concentrated in vacuo and filtered from MeOH. The solid was then collected, dissolved in dichloromethane, dried over Na2SO4 and concentrated under vacuum, affording the final pybox ligand. ( 137.9, 136.5, 128.4, 128.1, 127.9, 127.5, 127.2, 127.0, 126.9, 86.7, 74.9 . 8, 142.1, 140.6, 138.2, 129.6, 129.4, 128.7, 127.7, 127.4, 127.0, 90.9, 79.9 . 
2,6-Bis[(4S,5R)-4,5-diphenyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine
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